$159.85M
Revenue
$-298.34M
Net Income
19.18%
Gross Margin
-163.08%
Op. Margin
$-237.75M
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
|---|---|---|---|
| Total Revenue | $57.67M | $30.78M | $15.55M |
| Revenue Growth % (YoY) | nan% | nan% | nan% |
| Cost of Revenue | $41.71M | $22.29M | $11.55M |
| Gross Profit | $15.96M | $8.49M | $4.00M |
| Gross Margin % | 27.7% | 27.6% | 25.7% |
| Operating Expenses | $101.56M | $70.68M | $58.34M |
| Research & Development | $57.57M | $48.76M | $45.77M |
| Selling General & Admin | $44.00M | $21.92M | $12.57M |
| Operating Income | $-85.60M | $-62.19M | $-54.35M |
| Operating Margin % | -148.4% | -202.1% | -349.5% |
| Interest Expense | $1.48M | $14.44M | $11.10M |
| Other Income/Expense | $-3.63M | $-3.00K | $-4.19M |
| Income Before Tax | $-78.19M | $-133.41M | $-63.78M |
| Income Tax Expense | $-37.13M | - | - |
| Net Income | $-41.06M | $-133.41M | $-63.78M |
| Net Margin % | -71.2% | -433.5% | -410.2% |
| Basic EPS | 2.42 | -1.50 | -5.78 |
| Diluted EPS | 2.42 | -1.50 | -5.78 |
| Basic Shares Outstanding | - | 93.8M | 13.9M |
| Diluted Shares Outstanding | - | 93.8M | 13.9M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
|---|---|---|---|
| Cash & Cash Equivalents | $792.97M | $995.16M | $205.29M |
| Short-term Investments | $100.01M | - | - |
| Accounts Receivable | $46.13M | $5.13M | $5.64M |
| Other Current Assets | $11.72M | $7.42M | $8.73M |
| Total Current Assets | $963.17M | $1.02B | $234.11M |
| Property Plant & Equipment | $163.74M | $142.56M | $138.65M |
| Goodwill | $450.12M | $17.10M | $17.10M |
| Intangible Assets | $165.71M | - | - |
| Other Non-current Assets | $4.02M | $14.29M | $784.00K |
| Total Assets | $1.82B | $1.26B | $466.79M |
| Accounts Payable | $35.63M | $30.43M | $32.88M |
| Short-term Debt | $7.10M | - | - |
| Accrued Liabilities | $42.76M | $20.17M | $16.66M |
| Deferred Revenue | $116.14M | $95.20M | $82.71M |
| Other Current Liabilities | $9.42M | $9.91M | $6.50M |
| Total Current Liabilities | $213.58M | $164.93M | $147.44M |
| Other Non-current Liabilities | $17.28M | $26.61M | $19.68M |
| Total Liabilities | $635.00M | $307.37M | $411.42M |
| Common Stock | $17.00K | $16.00K | $2.00K |
| Retained Earnings | $-1.02B | $-979.22M | $-918.00M |
| Total Stockholders Equity | $1.19B | $948.82M | $-918.00M |
| Total Liabilities & Equity | $1.82B | $1.26B | $466.79M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
|---|---|---|---|
| Net Income | $-41.06M | $-133.41M | $-63.78M |
| Depreciation & Amortization | $9.62M | $13.54M | $7.92M |
| Stock-based Compensation | $12.65M | $5.19M | $1.19M |
| Change in Receivables | $-4.77M | $4.12M | $4.63M |
| Change in Payables | $-12.15M | $-5.30M | $-3.34M |
| Operating Cash Flow | $-67.26M | $-137.66M | $-84.62M |
| Capital Expenditure | $12.07M | $20.76M | $11.84M |
| Investing Cash Flow | $-380.80M | $-20.76M | $-11.84M |
| Stock Issued | $-25.00K | $943.74M | - |
| Financing Cash Flow | $245.03M | $1.02B | $180.44M |
| Net Change in Cash | $-203.03M | $858.43M | $83.98M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $30.78M | - | $102.18M | - |
| Cost of Revenue | $22.29M | - | $87.48M | - |
| Gross Profit | $8.49M | - | $14.71M | - |
| Operating Expenses | $70.68M | - | $189.79M | - |
| Research & Development | $48.76M | - | $142.55M | - |
| Selling General & Admin | $21.92M | - | $47.24M | - |
| Operating Income | $-62.19M | - | $-175.09M | - |
| Interest Expense | - | - | $14.44M | - |
| Other Income/Expense | $-3.00K | - | $4.53M | - |
| Income Before Tax | $-133.41M | - | $-257.28M | - |
| Income Tax Expense | - | - | - | - |
| Net Income | $-133.41M | $-53.45M | $-257.28M | - |
| Basic EPS | -1.50 | - | -7.25 | - |
| Diluted EPS | -1.50 | - | -7.25 | - |
| Basic Shares Outstanding | $93.85M | - | $40.39M | - |
| Diluted Shares Outstanding | $93.85M | - | $40.39M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $995.16M | $123.43M |
| Accounts Receivable | $5.13M | $1.00M |
| Other Current Assets | $7.42M | $3.45M |
| Total Current Assets | $1.02B | $180.72M |
| Property Plant & Equipment | $142.56M | $135.57M |
| Goodwill | $17.10M | $17.10M |
| Other Non-current Assets | $14.29M | $158.00K |
| Total Assets | $1.26B | $407.33M |
| Accounts Payable | $30.43M | $37.63M |
| Accrued Liabilities | $20.17M | $14.42M |
| Deferred Revenue | $95.20M | $108.07M |
| Other Current Liabilities | $9.91M | $10.84M |
| Total Current Liabilities | $164.93M | $179.38M |
| Other Non-current Liabilities | $26.61M | $25.96M |
| Total Liabilities | $307.37M | $415.37M |
| Common Stock | $16.00K | $1.00K |
| Retained Earnings | $-979.22M | $-767.62M |
| Total Stockholders Equity | $948.82M | $-767.62M |
| Total Liabilities & Equity | $1.26B | $407.33M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-133.41M | $-53.45M | $-257.28M | - |
| Depreciation & Amortization | - | - | $13.54M | - |
| Stock-based Compensation | - | - | $5.19M | - |
| Change in Receivables | - | - | $4.12M | - |
| Change in Payables | - | - | $-5.30M | - |
| Operating Cash Flow | - | - | $-137.66M | - |
| Capital Expenditure | - | - | $20.76M | - |
| Investing Cash Flow | - | - | $-20.76M | - |
| Stock Issued | - | - | $943.74M | - |
| Financing Cash Flow | - | - | $1.02B | - |
| Net Change in Cash | - | - | $858.43M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.